GENERAL ATLANTIC, L.P. Diversified Active

Location: New York, NY

CIK: 0001017645 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 15, 2026

Total Value: $2.148B (100.0% shares, 0.0% debt)

Holdings (12)

DLO DLOCAL 28.2%

Value $605M Shares 46,656,695 Est. Cost — Unrealized —

CHYM CHIME 18.5%

Value $398M Shares 21,259,683 Est. Cost — Unrealized —

XP XP, INC 18.2%

Value $392M Shares 20,566,133 Est. Cost — Unrealized —

ALKT ALKAMI 11.2%

Value $240M Shares 15,337,495 Est. Cost — Unrealized —

PHVS PHARVARIS 10.6%

Value $227M Shares 8,031,252 Est. Cost — Unrealized —

EWCZ EUROPEAN WAX CENTER 3.5%

Value $75.78M Shares 13,110,492 Est. Cost — Unrealized —

RVMD REVOLUTION MEDICINES 3.2%

Value $68.83M Shares 707,791 Est. Cost — Unrealized —

NRIX NURIX THERAPEUTICS 3.0%

Value $63.58M Shares 4,101,865 Est. Cost — Unrealized —

CNTA CENTESSA PHARMACEUTICALS 2.5%

Value $53.81M Shares 1,354,830 Est. Cost — Unrealized —

RSKD RISKIFIED 1.0%

Value $20.87M Shares 5,324,998 Est. Cost — Unrealized —

GROV GROVE COLLABORATIVE 0.1%

Value $3.168M Shares 2,474,859 Est. Cost — Unrealized —

BULL WEBULL 0.0%

Value $244K Shares 50,816 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
DLO	DLOCAL	46,656,695	$605M	28.2%	—	—	CL A	G29018101
CHYM	CHIME	21,259,683	$398M	18.5%	—	—	CL A	16935C109
XP	XP, INC	20,566,133	$392M	18.2%	—	—	CL A	G98239109
ALKT	ALKAMI	15,337,495	$240M	11.2%	—	—	COM	01644J108
PHVS	PHARVARIS	8,031,252	$227M	10.6%	—	—	COM	N69605108
EWCZ	EUROPEAN WAX CENTER	13,110,492	$75.78M	3.5%	—	—	CL A	29882P106
RVMD	REVOLUTION MEDICINES	707,791	$68.83M	3.2%	—	—	COM	76155X100
NRIX	NURIX THERAPEUTICS	4,101,865	$63.58M	3.0%	—	—	COM	67080M103
CNTA	CENTESSA PHARMACEUTICALS	1,354,830	$53.81M	2.5%	—	—	ADS	152309100
RSKD	RISKIFIED	5,324,998	$20.87M	1.0%	—	—	CL A	M8216R109
GROV	GROVE COLLABORATIVE	2,474,859	$3.168M	0.1%	—	—	CL A	39957D201
BULL	WEBULL	50,816	$244K	0.0%	—	—	ORD SHS	G9572D103